|
|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 395 active entries
Plot 79/80B, Sector 5, IMT Manesar,
GURGAON,HARYANA
India Phone: 91-124-4920000
Fax: 91-124-4365221
Description:
Premas Biotech – Enabling the Future of Biologics Premas Biotech is a global Contract Development and Manufacturing Organization (CDMO) based in India, specializing in the development and scalable manufacturing of biologics. With expertise spanning discovery to cGMP production, we empower biopharma companies, research institutes, and diagnostic developers to accelerate their pipelines with high-quality proteins, antibodies, and novel therapeutic candidates. Our Comprehensive Service Portfolio Cell Line Development - Host Cell Line Selection
- Gene Cloning & Vector Construction
- Stable Cell Line Generation
- Single-Cell Cloning & Productivity Screening
- Clone Stability Studies
- Master & Working Cell Banking
Scouting & Feasibility - Expression Feasibility Studies
- Codon Optimization & Sequence Engineering
- Protein Expression Screening
- Solubility & Aggregation Assessment
- Target Validation & Early Analytical Characterization
Process Development - Upstream Process Development (media/feed optimization, process intensification)
- Downstream Purification Development
- Yield Optimization & Process Characterization
- Technology Transfer to Manufacturing
Scale-Up & Manufacturing - Pilot-Scale Production (Non-GMP & cGMP)
- cGMP Manufacturing for Clinical Supply (DS & DP)
- Bioreactor Scale-Up & Batch Production
- Drug Product Fill-Finish Services
Analytical Development - Method Development, Qualification & Validation
- In-Process & Release Testing
- Bioassay Development
- ICH Stability Studies
- Impurity Profiling & Functional Assays
Proprietary Technologies - AXTEX-4D™ – A 3D cell culture platform that mimics human microenvironments, enabling predictive drug discovery, cancer biology studies, and cytotoxicity assays.
- D-Crypt™ – A robust yeast-based expression system for high-yield and scalable production of difficult-to-express proteins, therapeutics, and vaccines.
- C-QWENCE™ – A human phage display antibody library with diverse genetic representation, offering next-generation antibody discovery for therapeutics and diagnostics.
Why Premas? We bring end-to-end capabilities—from gene to IND-enabling studies—backed by strong analytical platforms (Mass Spec, HPLC, endotoxin determination, structural and stability studies, lyophilization expertise). With significant manufacturing capacity in microbial and mammalian systems, Premas is uniquely positioned to deliver novel biologics, biosimilars, therapeutic antibodies, vaccines, and high-quality proteins to global partners.
Selected Categories:
Last update of this entry: September 25, 2025
|